Literature DB >> 21596126

Preparation of polymeric nanoparticles of cyclosporin A using infrared pulsed laser.

Gen Takebe1, Tokio Takagi, Masumi Suzuki, Mitsuo Hiramatsu.   

Abstract

Nanoparticle formation of poorly water-soluble drugs is a means of providing much benefit for improving solubility and bioavailability. We showed that laser irradiation of drugs can be a novel tool for dispersing drug nanoparticles in water. Using our method, we were able to produce nanoparticles containing immunosuppressant drug, cyclosporin A, which shows poor solubility toward water, with high levels of the drug using polyvinyl pyrrolidone and sodium dodecyl sulfate as stabilizing agents. The absence of degradation products was confirmed and the loss of pharmaceutical activity with an inhibitory effect on the interleukin-2 production of Jurkat T cells did not occur. Cyclosporin A nanoparticles showed a spherical shape and their particle size was distributed uniformly around 200 nm. Powder X-ray diffraction analysis suggested that cyclosporin A in the nanoparticles was in an amorphous state. In the measurement of solubility rate, the nanoparticle formulation showed a higher rate than that which had not been processed. At present, although this laser irradiation technology has low productivity, it is expected as a new technology for drug nanoparticle manufacturing together with the development of a new laser device.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596126     DOI: 10.1016/j.ijpharm.2011.05.012

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

1.  Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.

Authors:  Melissa Guada; Victor Sebastián; Silvia Irusta; Esperanza Feijoó; María del Carmen Dios-Viéitez; María José Blanco-Prieto
Journal:  Int J Nanomedicine       Date:  2015-10-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.